Healthcare Pharmaceutical Biotech

BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline

August 4, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to provide a comprehensive update on the progress of its proprietary sublingual thin-film drug delivery pipeline. The Company continues to advance multiple pharmaceutical development programs, including Cladribine for multiple sclerosis, autoimmune disease expansion, Everolimus and...

Read more

Sourced Peptides BPC-157 Reviews 2026: Is This the Lot-Matched 5mg Research Upgrade Serious Buyers Have Been Searching For?

August 3, 2026 9:55 PM

Paid Advertorial and Affiliate Disclosure: This is paid promotional content and contains affiliate links. A commission may be earned if a qualified purchase is made, at no extra cost to the buyer. Product claims are attributed to Sourced Peptides unless an independent source is named. This article does not provide medical, dosing, preparation, or experimental advice. See the current BPC-157 page while checking the listed lot against the COA....

Read more

Viemed Healthcare Announces Second Quarter 2026 Financial Results

August 3, 2026 5:00 PM

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three and six months ended June 30, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended June 30, 2026...

Read more

Desert Oasis Healthcare Immediate Care Yucca Valley Moving to Expanded, State-of-the-Art Location

August 3, 2026 12:00 PM

Desert Oasis Healthcare (DOHC) is expanding access to convenient, high-quality healthcare in the Morongo Basin with the relocation of its Yucca Valley Immediate Care clinic to a larger, state-of-the-art space beginning August 3, 2026. The expansion reflects DOHC's continued commitment to investing in healthcare access for Yucca Valley and the greater Morongo Basin, bringing together immediate care, diagnostics, specialty services and wellness...

Read more

Medical Care Technologies Continues Rigorous Testing of MDCE Melanoma Scan While Evaluating Expansion Opportunities (OTC Pink:MDCE)

August 3, 2026 9:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today provided an update on the continued rigorous testing of its MDCE Melanoma Scan Beta platform and the Company's broader expansion outlook. The Company remains actively engaged in structured evaluation and model training for MDCE Melanoma Scan Beta, applying multi-phase testing protocols focused on image quality, consistency, and performance across varied datasets. These efforts form part of...

Read more

PharmaSmart Joins American Heart Association Innovators' Network to Advance Evidence-Based Chronic Disease Screening and Community Health Technology & Innovation

August 3, 2026 9:00 AM

PharmaSmart International LLC, a leader in clinically validated health screening technology and community-based chronic disease management solutions, has joined the American Heart Association® Center for Health Technology & Innovation's Innovators' Network. The Center is focused on building and fostering health technology relationships to develop innovative, evidence-based, and scalable solutions. The Innovators' Network is a consortium...

Read more

Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury

August 3, 2026 9:00 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, announced today results of an independent market assessment which identified a potential $94 billion total addressable market for Gemini, confirming the unmet medical need. The independent market assessment evaluated Gemini for the treatment of Stage 2 and Stage 3...

Read more

Christian Care Ministry (Medi-Share) Announces New Chief Financial Officer Mark Tjernagel

August 3, 2026 9:00 AM

Christian Care Ministry, which for more than 30 years has administered the nationally recognized Medi-Share health care sharing ministry, today announced that Mark Tjernagel has joined the organization as Chief Financial Officer. Bringing more than three decades of executive leadership experience within major Christian nonprofit organizations, Tjernagel will oversee the ministry's financial strategy and serve as a key member of the executive...

Read more

Strida Announces Nationwide Availability of Flat-Rate GLP-1 Weight-Loss Program

August 3, 2026 9:00 AM

Strida, a telehealth platform for medical weight loss and wellness, today announced the nationwide availability of its flat-rate, physician-supervised GLP-1 weight-loss program. Compounded semaglutide plans start at $159 per month and compounded tirzepatide plans at $195 per month, with medication, licensed physician care, dosage adjustments, unlimited provider messaging, supplies, and free discreet shipping all included in a single monthly...

Read more

BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula

August 3, 2026 8:00 AM

BioAdaptives, Inc. (OTCID:BDPT), a developer of natural, science-backed wellness solutions, today announced that the official opening of its commercial order window for XcellaraHeart™, the flagship product in the company's new Xcellara™ cellular wellness line, will take place later this week. Customers and distributors will soon be able to place orders directly through products.xcellara.com. Following last week's successful buyout and retirement...

Read more

Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026

August 3, 2026 8:00 AM

Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced plans to initiate the first phase of commercialization of its Pivot tubeless patch pump across five strategically selected U.S. markets beginning in October 2026. The initial rollout will include Atlanta, Cincinnati/Lexington,...

Read more

Who Does the Best Rhinoplasty in Seattle?

August 3, 2026 6:00 AM

Patients researching who does the best rhinoplasty in Seattle increasingly evaluate surgeons based on objective qualifications rather than promotional claims. Board certification, specialty training, procedural experience, patient safety, and consistent long-term outcomes have become some of the most important factors influencing surgeon selection. Based on these measures, Dr. David Santos of Seattle Plastic Surgery has established a reputation...

Read more

XVIVO Granted Additional Patient Enrollment in the US PRESERVE CAP Study for XVIVO Heart Assist Transport

August 3, 2026 3:50 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - XVIVO announces that the US Food and Drug Administration (FDA) has granted the company approval for additional patient enrollment in the Continued Access Protocol (CAP) study of 60 heart transplantations using XVIVO Heart Assist Transport. Last summer, XVIVO received approval to enroll up to 60 patients across 26 US transplant centers, with the final patient enrolled in March. Importantly, the...

Read more

AlzeCure Pharma Resolves on a Directed Share Issue to QuantumCell

August 3, 2026 2:10 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6) ("AlzeCure" or the "Company") announced in a press release on 1 July 2026 that the Company had entered into an out-licensing and collaboration agreement (the "Agreement") with the Danish company QuantumCell ApS regarding the NeuroRestore project ACD856. The press release disclosed, among other things, that part of the payment to AlzeCure would consist of a direct registration in the Company's...

Read more

Genflow Biosciences PLC Announces Patent Update

August 3, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), an emerging leader in the field of longevity research, announces progress across its two principal SIRT6 patent families covering its centenarian-derived SIRT6 variant (SIRT6c; N308K/A313S). US patent application covering the use of SIRT6c in NAFLD and NASH published Track One prioritized examination granted for the foundational in-licensed US SIRT6 compound of matter...

Read more

Lttl GLP-1 Review 2026: Could “Same Price at Every Dose” Be the Telehealth Pricing Shift Buyers Have Been Waiting For?

August 1, 2026 7:10 PM

This paid advertorial contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. Readers pay no added cost for using them. Platform, seller, pharmacy, and marketing claims are not independently endorsed. Review Lttl GLP-1 Latest Offer and Terms Prices, plans, shipping, and access may change. Clinical decisions also vary by patient. Check official policies before paying. Ask a qualified...

Read more

MigraClarity Reviews 2026: Is This the Doctor-Ready Migraine Tracker People Tired of Guessing Their Triggers Have Been Searching For?

August 1, 2026 6:15 PM

Disclaimers: This is a paid advertorial. A commission may be earned when purchases are made through links in this article. Product claims are attributed to the brand and are not independently endorsed. MigraClarity is marketed by the brand as a digital migraine-tracking tool. No FDA clearance, approval, or authorization was confirmed in the materials reviewed, and this article does not independently classify the product under FDA medical-device...

Read more

Shiny Smile Veneers 2026: How Long They Really Last, the 15-Month Crack-Cover Detail Behind the "3-Year Warranty," and What Daily Wear Is Actually Like

August 1, 2026 5:40 PM

Title reference: the "3-Year Warranty" and "15-month" figures above are Shiny Smile Veneers' own published warranty terms, quoted from the brand's FAQ and terms pages at getshinysmileveneers.com. This publication doesn't independently substantiate the brand's coverage claims; the sections below explain what those terms actually say so you can verify them yourself. Quick disclosure before you read further: This is a paid advertorial. A commission...

Read more

NEI Launches Whole-Child Health Initiative Following New Florida Guidance on Psychiatric Medications for Children

August 1, 2026 4:15 PM

St. Petersburg organization expands support for families seeking comprehensive evaluations, full support and alternatives before medication. The Neurodivergent Empowerment Institute (NEI) is launching a new whole-child health initiative in response to recently released guidance from the Florida Department of Health concerning the use of psychiatric medications in children ages 5 through 17. The new guidance urges healthcare providers to conduct...

Read more

The Cannabis Industry Built on Schedule III. Federal Courts Are About to Decide Whether That Foundation Holds

August 1, 2026 3:30 PM

The cannabis industry has largely treated the Attorney General's April 2026 Marijuana Rescheduling Order as a settled foundation for future growth. The federal courts have not yet decided whether that foundation is lawful. MMJ International Holdings, Inc. and its subsidiaries are currently involved in multiple separate federal matters examining different aspects of the government's treatment of cannabis: A D.C. Circuit challenge to the...

Read more